PublicNews18: Dr ZinX exploits the hinokitiol + zinc anti-viral properties
Zinc + Hinoktiol Much of what makes Hydroxychloroquine effective in combination with Zinc is believed to be its Zinc Ionophore capability. That is, the ability for Hydroxychloroquine to transport Zinc into cells and inhibit viral replication. Hinokitiol is also a Zinc Ionophore and was discovered in Japan in 1936. Hinokitiol is naturally occurring and draws its advantage from having low toxicity, hence,
Zinc + Hinoktiol its wide inclusion in consumer oral care products. It is also an approved food additive in Japan, with ‘Hinoki Clinical jp’ selling Hinokitiol based products since 1956. Hydroxychloroquine requires a prescription, alternatively Hinokitiol can be purchased in consumer oral care products without restriction in both the EU and the USA.
Antiviral Properties of Zinc + Hinoktiol
Zinc + Hinoktiol The antiviral activity of Zinc depends on the intracellular availability of Zinc. In vitro, Zinc doses of > 2 μM inhibits replication of SARS-CoV by inhibiting RNA-dependent RNA polymerase Zinc. Zinc also has direct antiviral properties that include stimulation of a variety of antiviral signaling events. For example, Zinc levels have been associated with inhibition of IFN-l3 signaling, actions which may moderate cytokine storm associated with worse outcome in patients infected with SARS-CoV.
Role of Zinc + Hinokitiol
Zinc + Hinokitiol (hk) is a Zinc ionophore that accelerates the uptake of Zinc Coronavirus inside the cell. This action increases the concentration of intracellular Zinc, potentiating its antiviral activity. The continuous presence of Zinc ionophore such as hk is required for Zinc ions to maintain the antiviral properties.Zinc Coronavirus At doses of >0.2 μg/ml hk directly inhibits viral and bacterial activities. A coronavirus disinfectant patent reported that a content of 0.02 to 0.2% by mass hinokitiol was effective.
what makes this combination of Zinc + Hinoktiol and Hinokitiol so special?
Zinc Coronavirus is a trace mineral which plays a very important role in supporting the immune system by participating to the growth and regulation of immune cells as well as the production of immune mediators like antibodies. Moreover it has been shown to have direct antiviral properties as well as stimulating properties for antiviral immunity. An abundance of evidence has demonstrated the role of zinc against a variety of viruses such as influenza, herpes simplex and hepatitis. Many case studies reported the susceptibility of people with zinc deficiencies to developing infections in general, and specifically viral infections like the flu or hepatitis.
Hinokitiol is a natural agent extracted from the wood of trees of the Cupressaceae family with proven antibacterial and antifungal properties. It is also a chelator of divalent metal ions, which means that it can bind to ions like zinc (Zn2+) to facilitate their entry to the infected cells hence
enabling an increase in intracellular zinc levels which in turn is responsible for the inhibition of viral replication.
Finally using anti-infective preparations like Dr zinX oral spray is not meant to replace other simple preventative measures like frequent hand washing, disinfecting surfaces and avoiding
Available evidence suggests that a combination of Zinc and Hinokitiol are synergistic in inhibiting growth of viruses including SARS-COV. Dr ZinX Oral Spray is a novel patented oral formulation (Patent number: 2020900820) consisting of Zinc and Hinokitiol. Dr ZinX has the potential to reduce the viral load in oral mucosa, reducing chances of human-human transmission and severity of COVID-19.
About the Writer
Dr. Joram Nyandat is a public health specialist. He is currently a paediatrician and intensive care physician at the Charlotte Maxeke Johannesburg Academic Hospital.
For more information visit drzinx.com
Company Name: Astivita Limited